E233-1683 Screening compound: 2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

E233-1683 Screening compound: 2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide
E233-1683 Screening compound: 2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E233-1683
2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E233-1683

Molecular Formula

C24H21ClN4O2 (C24 H21 ClN4 O2)

Compound Name

2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

IUPAC name

2-[(3-chlorophenyl)methyl]-8-methyl-N-[(pyridin-2-yl)methyl]-2H4H5H-furo[23-g]indazole-7-carboxamide

SMILES

Cc1c(C(NCc2ncccc2)=O)oc2c1-c1nn(Cc3cccc(Cl)c3)cc1CC2

InChI

InChI=1S/C24H21ClN4O2/c1-15-21-20(31-23(15)24(30)27-12-19-7-2-3-10-26-19)9-8-17-14-29(28-22(17)21)13-16-5-4-6-18(25)11-16/h2-7,10-11,14H,8-9,12-13H2,1H3,(H,27,30)

InChI Key

UFFQIEXSOMPLJF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14850651

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.91

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.988

Distribution Coefficient, logD

3.988

Water Solubility, LogSw

-4.52

Polar Surface Area

57.793

Acid Dissociation Constant (pKa)

12.08

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

E233-1683 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E233-1683 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E233-1683?
Check Price and Availability of E233-1683, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E233-1683 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E233-1683
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E233-1683
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E233-1683 available by request